Alain Kuyumjian
Advises clients on public and private capital markets debt and equity transactions. Also provides general corporate advice to U.S. and Latin American companies.
Alain advises clients on public and private capital markets debt and equity transactions, including initial public offerings, high-yield and investment-grade debt offerings, sovereign debt offerings and liability management transactions. His work spans a range of industries, including financial services, biotech, industrials and consumer products.
He also advises corporate clients, primarily based in the United States and Latin America, on general corporate matters, including corporate governance and securities law compliance.
Experience
Alain’s representative transactions include:
- The initial public offerings of Applied Therapeutics, ATAI Life Sciences, Biodesix, CureVac, Cynapsus Therapeutics, FTAC Hera, Graña y Montero, Kala Pharmaceuticals, Prime Medicine and RE/MAX
- CMPC’s sustainability-linked notes offering and Sociedad Química y Minera de Chile’s green bonds
- ATM programs for Applied Therapeutics and Biodesix
- Government of Belize marine conservation-linked debt restructuring
- Rights offerings by Enersis, Sociedad Química y Minera de Chile and Itaú Corpbanca
- Canadian National Railway, Entel, Euronet Worldwide and Industrias Peñoles debt offerings
- Banco Santander’s concurrent exchange offers in the United States and Mexico to acquire up to 25% of Santander Mexico
- Alsea’s equity follow-on financing for the Vips acquisition
- Santander Mexico’s global equity offering and listing on the NYSE and debt financings
Insights
Recognition
Latinvex – “Latin America’s Rising Legal Stars,” 2015
Education
- with great distinction
- Editor, McGill Law Journal
Clerkships
Qualifications and admissions
- Province of Ontario
- State of New York